Health Care & Life Sciences » Pharmaceuticals | Inner Mongolia Furui Medical Science Co. Ltd.

Inner Mongolia Furui Medical Science Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,827.50
84,805.10
95,057.30
148,131.80
93,863.30
45,174.90
Depreciation, Depletion & Amortization
15,900.70
38,159.60
21,989.00
34,959.60
45,716.80
44,982.60
Other Funds
6,948.30
86,741.80
252,168.40
2,097.70
6,780.50
27,448.90
Funds from Operations
16,202.90
140,846.80
119,744.50
160,776.50
160,711.40
147,660.60
Changes in Working Capital
11,980.20
89,971.10
43,244.50
2,160.20
25,989.70
61,065.20
Net Operating Cash Flow
28,183.20
50,875.70
162,989.00
158,616.30
134,721.70
86,595.40
Capital Expenditures
237,512.90
83,595.40
127,450.40
213,503.10
34,072.00
Sale of Fixed Assets & Businesses
-
358.00
160.00
5,875.40
10,451.60
Purchase/Sale of Investments
-
261.30
272,763.50
223,799.20
264,987.40
Net Investing Cash Flow
117,375.10
98,800.00
145,473.10
270,330.80
288,607.80
Cash Dividends Paid - Total
-
-
26,345.80
26,324.60
26,324.60
Issuance/Reduction of Debt, Net
25,274.40
13,254.90
9,149.70
30,215.30
14,850.00
Net Financing Cash Flow
32,222.70
73,486.90
234,972.40
58,637.60
18,255.10
Net Change in Cash
55,743.10
18,334.40
563,772.00
147,832.40
141,010.70
Free Cash Flow
209,329.70
32,719.70
35,538.60
54,886.80
100,649.80
Deferred Taxes & Investment Tax Credit
8,097.50
12,634.40
4,866.30
26,257.80
13,069.30
30,054.20
Net Assets from Acquisitions
-
15,823.90
-
-
-
Other Sources
120,137.70
-
-
161,096.00
-
Exchange Rate Effect
1,226.10
7,228.20
20,337.50
22,519.80
31,130.50

About Inner Mongolia Furui Medical Science Co.

View Profile
Address
7/F, Building 2, Kunsha Center
Beijing Beijing 100027
China
Employees -
Website http://www.fu-rui.com
Updated 07/08/2019
Inner Mongolia Furui Medical Science Co., Ltd. engages in the provision of liver fibrosis diagnosis and treatment services. It focuses on disease diagnosis, drug treatment, and chronic disease management. Its business includes pharmaceutical production and sales, equipment research and development and sales, and medical services.